The FDA granted emergency use authorization to an InflaRx antibody drug that treats hospitalized Covid-19 patients. But Pardes Bioscience’s coronavirus journey is ending following the Phase 2 failure of an antiviral that was expected to compete with Pfizer’s Paxlovid.
About 51% of U.S. adults are in favor of the Covid-19 public health emergency still in effect, while 39% said it is no longer needed, a recent Morning Consult survey found. Americans’ opinions varied based on political party, generation, race/ethnicity and location.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Leyden Labs is developing nasal spray medicines to prevent respiratory viral infections. The company’s Series B round of funding follows a licensing deal that gives the biotech rights to a Janssen antibody designed to address the two types of influenza that cause seasonal flu.
Reflecting on lessons learned from the pandemic, healthcare leaders pointed to the lack of coordination and glaring health disparities that hampered the U.S. pandemic response. Going forward, they hope to see future change in the healthcare system.
If we continue to apply the technology without widespread agreement to these basic premises, we could dissolve people’s trust before we even earn it.
As states begin to roll out vaccines to the broader public, Google will make it easier for people to find out when they are eligible and where they can get a vaccine. The effort is part of a broader push, including $150 million in grants to promote vaccine education and equitable access.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Beckman Coulter said it would file for an emergency use authorization for a SARS-CoV-2 antigen test that costs only $4.
Covid-19’s impact on children represents a tiny fraction of the suffering and death experienced by vulnerable adults. Yet it's pretty serious having caused 154 deaths and more than 7,500 hospitalizations as of Dec. 3 among people 19 and younger in the United States.
The FDA authorized an at-home antigen test for Covid-19 developed by Ellume. It does not require a prescription.
Even as FDA engaged in intense deliberations ahead of Friday’s authorization of the Pfizer and BioNTech Covid vaccine, and days before the initial 6.4 million doses were to be released, hospitals across the country have been grappling with how to distribute the first scarce shots.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The vaccine was developed in record time, a big scientific accomplishment, even though the agency's move follows an unusual level of pressure from President Trump's White House, renewing concerns that politics drove the vaccine process even as the first doses are shipped.
The nonbinding recommendation is a final hurdle before an official emergency use authorization for the vaccine, which could be the first shot approved for use in the U.S. Distribution, however, will remain a challenge.
The COVID-19 Vaccination Assistant will provide information about the new vaccines to help allay fears among the U.S. public. It will also help people schedule their vaccinations and connect them with rideshare services to make it to their appointment.
A health journalist, a physician and a former foreign correspondent sits down with Dr. Anthony Fauci for a lengthy Q&A about safety during Covid times.
Bandannas, like plastic face shields, allow the virus to escape out the bottom in aerosolized particles that can hang in the air for hours. And gaiters are often made of such thin material that they don’t trap as much virus as cloth masks.